RxSight, Inc. Increase (Decrease) in Deferred Revenue
RxSight, Inc. (RXST) reported Increase (Decrease) in Deferred Revenue of $3.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-05
- 2026-06-30: Increase (Decrease) in Deferred Revenue 6 month $3.50M.
- 2025-06-30: Increase (Decrease) in Deferred Revenue 6 month $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 6 month |
|---|---|
| 2026-06-30 | $3.50M 10-Q · filed 2026-08-05 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |